Oncology Director of Nursing (West LA)
The START Center for Cancer Research
Summary
We are seeking an Oncology Director of Nursing at our outpatient Phase I clinical research site. This role will provide supervision to all clinic nurses, infusion nurses, nurse navigators, referral intake team and schedulers. The Director of Nursing provides professional guidance and development to the nurses and staff that he/she supervises, ensures organizational goals and objectives are met by the departments under their responsibility, and ensures on-going training, education and high-quality care are delivered through effective processes and systems in his/her respective departments.
Job description
Essential Responsibilities
- Ensure high quality, coordinated care by communicating care plans and schedules to patients, return patient calls promptly and provide same-day/next day visits for patients with time-sensitive issues.
- Review all incoming protocols for feasibility with respect to nursing operations and study coordinator teams. Manage study allocation equitably across study coordinator team members.
- Provide effective, proactive leadership to team members, including but not limited to managers, clinic nurses, infusion nurses, nurse navigators, schedulers, and referral intake coordinators.
- Provide effective training and ensure competency of staff and management team for respective job roles.
- Maintain adherence and demonstrate ongoing compliance for all departments with internal standard operating procedures and participate in ongoing review and updates as needed for the good of the patients, sponsors and organization.
- Track and maintain effective standards and metrics with respect to referral intake, new patient visit, enrollment, and screening steps in research process.
- Supervise nurse navigators and support growth goals of clinical research program with respect to new patient referrals and accruals.
Required Education and Experience
- Bachelor's degree in nursing.
- RN license in good standing with state.
- ONS/ONCC chemotherapy immunotherapy certificate course.
- Knowledge of GCP, GDPR and federal clinical research regulations required in US and Europe.
- Must be familiar with Microsoft Office applications and clinical documentation systems.
Preferred Education and Experience
- Advanced degree in nursing or leadership.
- Oncology Certified Nurse (OCN).
- Previous experience in oncology clinical research.
Requirements
- Bachelor's degree in nursing
- RN license in good standing with state
- ONS/ONCC chemotherapy immunotherapy certificate course
- Knowledge of GCP, GDPR and federal clinical research regulations in US and Europe
- Familiar with Microsoft Office applications and clinical documentation systems
- Advanced degree in nursing or leadership (preferred)
- Oncology Certified Nurse (OCN) (preferred)
- Previous experience in oncology clinical research (preferred)
Benefits
- 401(k) Matching
- Annual Performance Bonus
- Paid Time Off
- Paid Holidays
- Medical, Dental & Vision
- Life Insurance
- Disability Insurance
- Employee Assistance Program
- Flexible FSA
- HSA Plans
Company overview
The START Center for Cancer Research (START) is a global leader in early-phase oncology clinical trials, providing specialized access to novel anti-cancer therapies through its extensive network of community-based research sites. Founded in Texas in 2007, START has established itself as the world's largest community-based early-phase oncology research organization with operations spanning the United States and Europe. The company operates 10 research locations globally and has conducted over 1,500 early-phase clinical trials, contributing to the development and approval of 45 FDA/EMA-approved cancer therapies. START's unique model embeds clinical trial capabilities within community oncology centers, enabling patients to access cutting-edge treatments where they already receive care. With more than 30 Principal Investigators and over 100,000 square feet of world-class research facilities, the organization focuses on accelerating the transition from clinical trials to approved treatments. START's comprehensive approach includes genetic tumor profiling, targeted therapies, and multi-specialty services, all delivered through a patient-centered framework that prioritizes accessibility and scientific rigor in cancer research.